NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo

Overview of attention for article published in OncoTargets and therapy, April 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 1 news story.

(MedPage Today) -- A rare but deadly endocrine malignancy with no effective drug treatments may respond to targeted therapies…